News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Legault Pierre
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 10,000 shares
@ $23.0159, valued at
$230.2k
Sold 14,000 shares
@ $23.0159, valued at
$322.2k
Exercised 10,000 options to buy
@ $9.63, valued at
$96.3k
Exercised 14,000 options to buy
@ $8.93, valued at
$125k
|
|
| 02/03/2022 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 16,000 shares
@ $0 |
|
| 01/05/2022 |
4
| Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $60.87, valued at
$1.2M
|
|
| 12/22/2021 |
4
| Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc|
Txns:
| Exercised 7,603 shares
@ $8.41, valued at
$63.9k
Sold 7,603 shares
@ $57.02, valued at
$433.5k
Exercised 44,537 shares
@ $8.44, valued at
$375.9k
Sold 44,537 shares
@ $57.11, valued at
$2.5M
Exercised 97,860 shares
@ $8.48, valued at
$829.9k
Sold 97,860 shares
@ $58.01, valued at
$5.7M
Exercised 7,603 options to buy
@ $0
Exercised 44,537 options to buy
@ $0
Exercised 97,860 options to buy
@ $0 |
|
| 12/22/2021 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 20,000 shares
@ $21.0125, valued at
$420.3k
Sold 24,000 shares
@ $22.0086, valued at
$528.2k
Exercised 20,000 options to buy
@ $7.08, valued at
$141.6k
Exercised 24,000 options to buy
@ $7.88, valued at
$189.1k
|
|
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc|
Txns:
| Exercised 10,000 shares
@ $8.78, valued at
$87.8k
Sold 10,000 shares
@ $30, valued at
$300k
Exercised 10,000 options to buy
@ $0 |
|
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 02/14/2020 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 24,000 options to buy
@ $9.47, valued at
$227.3k
|
|
| 01/14/2020 |
4
| Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 12,480 shares
@ $0 |
|
| 01/06/2020 |
4
| Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc|
Txns:
| Granted 32,000 options to buy
@ $9.82, valued at
$314.2k
|
|
| 07/11/2019 |
4
| Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 25,000 options to buy
@ $8.78, valued at
$219.5k
|
|
| 06/12/2019 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 24,000 options to buy
@ $7.88, valued at
$189.1k
|
|
| 05/30/2019 |
4
| Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc|
Txns:
| Granted 116,827 options to buy
@ $14, valued at
$1.6M
|
|
| 11/26/2018 |
4
| Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 36,650 options to buy
@ $8.01, valued at
$293.6k
|
|
| 06/22/2018 |
4
| Legault Pierre (Director) has filed a Form 4 on ARMO BioSciences, Inc.|
Txns:
| Disposed/sold 18,000 options to buy
@ $39.97, valued at
$719.5k
Disposed/sold 55,765 options to buy
@ $6.7343, valued at
$375.5k
|
|
| 05/25/2018 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 14,000 options to buy
@ $8.93, valued at
$125k
|
|
| 03/28/2018 |
4
| Legault Pierre (Director) has filed a Form 4 on ARMO BioSciences, Inc.|
Txns:
| Granted 18,000 options to buy
@ $39.97, valued at
$719.5k
|
|
| 02/12/2018 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 10,000 options to buy
@ $9.63, valued at
$96.3k
|
|
| 05/19/2017 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 10,000 options to buy
@ $13.58, valued at
$135.8k
Granted 5,000 options to buy
@ $13.58, valued at
$67.9k
|
|
| 01/05/2017 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc |
| 11/03/2016 |
4
| Legault Pierre (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Disposed/sold 6,111 options to buy
@ $43.83, valued at
$267.8k
Disposed/sold 535 options to buy
@ $42.93, valued at
$23k
Disposed/sold 15,500 options to buy
@ $16.52, valued at
$256.1k
Disposed/sold 17,778 options to buy
@ $7.91, valued at
$140.6k
Disposed/sold 17,695 options to buy
@ $8.19, valued at
$144.9k
|
|
| 01/14/2016 |
4
| Legault Pierre (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Granted 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
| 11/12/2015 |
4
| Legault Pierre (CEO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 646,930 shares
@ $0 |
|
| 07/13/2015 |
4
| Legault Pierre (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Granted 15,500 options to buy
@ $16.52, valued at
$256.1k
|
|
|
|
|